aroxetine is an antidepressant agent, which affects via selective inhibition of serotonin reuptake. It is effective for the treatment of depression, obsessive compulsive disorder, panic disorder and anxiety disorder. These agents are widely preferred because of their favourable side effects and safety profiles. 1, 2 Severe hepatotoxicity associated with paroxetine is a rare condition and only a few cases have been reported in the literature. Clinical and laboratory improvement was observed in all of cases after the cessation of the drug. [3] [4] [5] [6] [7] [8] [9] [10] Here we report a case who was treated with paroxetine because of depressive symptoms and developed a severe hepatocellular toxic hepatitis, which completely recovered after the cessation of the drug.
Paroxetine Induced Toxic Hepatitis:
Case Report A AB BS ST TR RA AC CT T Paroxetine is an antidepressant agent, which affects via selective inhibition of serotonin reuptake. It is widely used for the treatment of depression, obsessive compulsive disorder, panic disorder and anxiety disorder. Although it has low side effects and a high safety profile, some cases of severe toxic hepatitis associated with paroxetine have been reported. Hepatotoxicity can be hepatocellular, cholestatic or mixed type. It is generally idiosyncratic and unpredictable, however patients with high risk such as coexisting liver disease and use of other potential hepatotoxic drugs, should be monitored carefully for hepatotoxicity while using this drug. Here we report a case of severe toxic hepatitis related to use of paroxetine. The patient recoverd completely after the the drug was stopped. 1 1) 
CASE REPORT
A 34-year-old woman was admitted to our clinic because of weakness that persisted for 1 month. In her history, she had no diseases except type 2 diabetes for 1 year. She did not use alcohol or any herbal medicine. She has used paroxetine 20 mg daily for 1 month, because of depression. Laboratory findings were as follows: serum alanine aminotransferase ( 
DISCUSSION
Paroxetine is a selective serotonin reuptake inhibitor and a popular choice for depression therapy worldwide. It has a low side-effect profile, even at high doses. 1 Altough transient mild elevations of liver enzymes have been observed with use of paroxetine, 11, 12 severe hepatoxicity is a rare condition and only ten cases were reported in the literature. Hepatotoxicity can be hepatocellular, cholestatic or mixed type.
3-10 Diagnosis of toxic hepatitis was supported by liver biopsy in some of these cases, while it was considered unnecessary in the others because of improvement within days after the cessation of the drug. In cases reported in the literature, liver enzymes completely improved in a follow-up period ranging from 1 week to 6 months and all cases showed favourable outcome.
Paroxetine is metabolized by two major liver enzymes. Lack of cytochrome P450 2D6 enzyme activity was detected in the patients with poor metabolization of this drug. 13, 14 In addition, elderly patients achive higher plasma paroxetine concentrations than younger cases using similar doses. 15 The hepatocellular damage of paroxetine seems to be an idiosyncratic reaction rather than a dose-dependent effect. 4, 6 It is unpredictable and usually does not require the monitorization of liver enzymes. However, in the presence of risk factors such as pre-existing cirrhosis and use of other hepatotoxic drugs, patients should be monitored carefully. 6 In our case, severe elevations of liver enzymes, which were hepatocellular type, were detected 1 month after the initiation of paroxetine. Liver enzymes gradually decreased within days and completely improved at 4 weeks after the cessation of the drug. Liver biopsy was considered unnecessary because of the exclusion of other possible etiologic factors for hepatitis and the rapid improvement of transaminase levels. Considering the findings and no use of any other hepatotoxic drug, this clinical condition was diagnosed as paroxetine induced hepatocellular toxic hepatitis.
In conclusion, hepatotoxicity associated with paroxetine is a rare condition, but it can occur. Severe liver injury can develop with the use of these drugs and especially patients with high risk should be monitored for hepatotoxicity during the treatment period.
